• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Elife . Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform

tetano

Editor, Senior Moderator
Elife


. 2023 Nov 21:12:RP89035.
doi: 10.7554/eLife.89035. Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform

Enja Tatjana Kipfer[SUP] #[/SUP][SUP] 1 [/SUP], David Hauser[SUP] #[/SUP][SUP] 1 [/SUP], Martin J Lett[SUP] 1 [/SUP], Fabian Otte[SUP] 1 [/SUP], Lorena Urda[SUP] 1 [/SUP], Yuepeng Zhang[SUP] 1 [/SUP], Christopher M R Lang[SUP] 1 [/SUP], Mohamed Chami[SUP] 2 [/SUP], Christian Mittelholzer[SUP] 1 [/SUP], Thomas Klimkait[SUP] 1 [/SUP]



Affiliations
Abstract

Reverse genetic systems enable the engineering of RNA virus genomes and are instrumental in studying RNA virus biology. With the recent outbreak of the coronavirus disease 2019 pandemic, already established methods were challenged by the large genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Herein we present an elaborated strategy for the rapid and straightforward rescue of recombinant plus-stranded RNA viruses with high sequence fidelity using the example of SARS-CoV-2. The strategy called CLEVER (CLoning-free and Exchangeable system for Virus Engineering and Rescue) is based on the intracellular recombination of transfected overlapping DNA fragments allowing the direct mutagenesis within the initial PCR-amplification step. Furthermore, by introducing a linker fragment - harboring all heterologous sequences - viral RNA can directly serve as a template for manipulating and rescuing recombinant mutant virus, without any cloning step. Overall, this strategy will facilitate recombinant SARS-CoV-2 rescue and accelerate its manipulation. Using our protocol, newly emerging variants can quickly be engineered to further elucidate their biology. To demonstrate its potential as a reverse genetics platform for plus-stranded RNA viruses, the protocol has been successfully applied for the cloning-free rescue of recombinant Chikungunya and Dengue virus.

Keywords: Chikungunya; Dengue; One Health; RNA virus; SARS-CoV-2; cell biology; human; infectious disease; microbiology; reverse genetics.

 
Back
Top Bottom